These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2737796)

  • 1. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
    Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
    Raz I; Hussein Z; Samara E; Ben-David J
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
    Hasan MM; Najib NM; Muti H
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans.
    Mascher H
    Drug Des Deliv; 1989 Jun; 4(4):303-11. PubMed ID: 2775450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
    Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
    Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
    Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
    J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
    Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
    Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
    Iqbal Z; Khan R; Nasir F; Khan JA; Rashid A; Khan A; Khan A
    Pak J Pharm Sci; 2011 Oct; 24(4):435-43. PubMed ID: 21959802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
    Walter K; von Nieciecki A
    Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
    Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
    Lissy M; Stiff DD; Kowalski MM; Moore KA
    Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects.
    Hasan MM; Najib NM; Rawashdeh NM; Sallam EN; Shubair MS; Alawneh Y
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):178-83. PubMed ID: 2071269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
    el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration].
    Vens-Cappell B; Hilgenstock C; Gellert M; Kühle K; Reifferscheid I; Winckler P; Bührens KG
    Arzneimittelforschung; 1993 Mar; 43(3):346-50. PubMed ID: 8489566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.